Pricing Log in Create free account

Veradermics Incorporated (MANE) vs PTC Therapeutics, Inc. (PTCT)

Veradermics Incorporated and PTC Therapeutics, Inc. are both Biotechnology companies. Veradermics Incorporated and PTC Therapeutics, Inc. are of similar size ($5.5B and $5.4B). Veradermics Incorporated has the higher net margin (0.00% vs −9.17%) and the lower return on invested capital (0.00% vs 17.7%). Across the 12 metrics below, PTC Therapeutics, Inc. leads on 8 and Veradermics Incorporated on 4.

Valuation

Metric MANE PTCT Biotechnology median
P/E n/m n/m 10.26
P/S n/m 4.76 9.18
P/B 6.37 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 32.37 0.65
EV/Sales n/m 5.37 8.98
Earnings yield (35.79%) (1.99%) (34.89%)
Free cash flow yield (2.37%) (4.72%) (24.52%)

Profitability

Metric MANE PTCT Biotechnology median
Gross margin — 93.20% 65.16%
Operating margin 0.00% 12.78% 0.00%
Net margin 0.00% (9.17%) 0.00%
Free cash flow margin 0.00% (22.43%) 0.00%
Return on equity 0.00% 61.08% (50.12%)
Return on assets (20.86%) (3.62%) (45.60%)
Return on invested capital 0.00% 17.66% 0.00%

Growth

Metric MANE PTCT Biotechnology median
Revenue growth (TTM) — (35.05%) 6.26%
EPS growth (last fiscal year) (211.38%) 264.48% 29.88%
Revenue growth, 5-year CAGR — 35.37% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MANE PTCT Biotechnology median
Debt to equity 0.00 (14.86) 0.00
Current ratio 70.53 3.27 4.89
Net debt to EBITDA 1.96 0.73 1.01

Dividend

Metric MANE PTCT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MANE PTCT Biotechnology median
Market cap 5.37b 5.49b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack